| __timestamp | AbbVie Inc. | Alpine Immune Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 12199547 |
| Thursday, January 1, 2015 | 4285000000 | 16054000 |
| Friday, January 1, 2016 | 4366000000 | 23316000 |
| Sunday, January 1, 2017 | 4982000000 | 10626000 |
| Monday, January 1, 2018 | 10329000000 | 28970000 |
| Tuesday, January 1, 2019 | 6407000000 | 35847000 |
| Wednesday, January 1, 2020 | 6557000000 | 27185000 |
| Friday, January 1, 2021 | 7084000000 | 58742000 |
| Saturday, January 1, 2022 | 6510000000 | 70243000 |
| Sunday, January 1, 2023 | 8453000000 | 80904000 |
| Monday, January 1, 2024 | 12791000000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, AbbVie Inc. and Alpine Immune Sciences, Inc. have showcased contrasting approaches to R&D investment.
From 2014 to 2023, AbbVie consistently allocated substantial resources to R&D, with expenditures peaking at approximately $8.5 billion in 2023. This represents a staggering 156% increase from their 2014 spending. In contrast, Alpine Immune Sciences, a smaller player, has shown a more modest growth trajectory, with R&D expenses rising from around $12 million in 2014 to $81 million in 2023, marking a 566% increase.
This disparity highlights the different scales and strategies of these companies, with AbbVie leveraging its vast resources to maintain a competitive edge, while Alpine focuses on targeted innovation within its niche.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Zoetis Inc.
AbbVie Inc. or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
R&D Insights: How AbbVie Inc. and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: AbbVie Inc. vs Vericel Corporation
Research and Development Investment: AbbVie Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Taro Pharmaceutical Industries Ltd.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.